Aurora Cannabis Inc. (NASDAQ:ACB) finished Friday with a subtraction of -$0.02 to close at $0.44, a downside of -3.72 percent. An average of 3,479,300 shares of common stock have been traded in the last five days. There was a fall of -$0.0673 in the past week, and it reached a new high 1 time over the past 12 months. The last 20 days have seen an average of 3,931,120 shares traded, while the 50-day average volume stands at 4,174,246.
ACB stock has decreased by -10.07% in the last month. The company shares reached their 1-month lowest point of $0.4340 on 08/25/23. With the stock rallying to its 52-week high on 02/02/23, shares of the company touched a low of $0.46 and a high of $1.73 in 52 weeks. It has reached a new high 7 times so far this year and lost -51.99% or -$0.4797 in price. In spite of this, the price is down -74.33% from the 52-week high.
Valuation Metrics
Aurora Cannabis Inc. (ACB) stock’s beta is 2.57. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 0.92, the price-to-book (PB) ratio at 0.33.
Financial Health
The quick ratio of Aurora Cannabis Inc. for the three months ended March 30 was 1.60, and the current ratio was 2.30, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.16 and a total debt to equity ratio of 0.33 for the quarter ending March 30. Aurora Cannabis Inc.’s EBITDA margin for the year ending March 30 is -90.34%, while its operating margin for the same period stands at -97.30%. Its gross profit as reported stood at $16.77 million compared to revenue of $174.88 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Aurora Cannabis Inc.’s return on assets was -22.90%.
Earnings Surprise
In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$1.32 billion in the quarter, while revenues were grew 100.0%. The analyst consensus anticipated Aurora Cannabis Inc.’s latest quarter earnings to come in at -$0.05 per share, but it turned out to be -$0.18, a -260.00% surprise. For the quarter, EBITDA amounted to -$11.99 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Aurora Cannabis Inc. (ACB) price momentum. RSI 9-day as of the close on 25 August was 21.49%, suggesting the stock is oversold, with historical volatility in this time frame at 28.57%.
As of today, ACB’s price is $0.4741 -13.19% or -$0.0673 from its 5-day moving average. ACB is currently trading -16.75% lower than its 20-day SMA and -33.90% lower than its 100-day SMA. However, the stock’s current price level is -17.91% below the SMA50 and -67.19% below the SMA200.
The stochastic %K and %D were 4.65% and 4.52%, respectively, and the average true range (ATR) was 0.0245. With the 14-day stochastic at 6.80% and the average true range at 0.0262, the RSI (14) stands at 29.64%. The stock has reached -0.0299 on the 9-day MACD Oscillator while the 14-day reading was at -0.0462.
Analyst Ratings
Canaccord Genuity upgraded Aurora Cannabis Inc. (NASDAQ: ACB) to a a Hold rating in its most recent analyst report. Previously, the stock was rated as a Sell. The consensus rating for Aurora Cannabis Inc. (ACB) among analysts is Hold. According to current brokerage recommendations, 0 brokerage firms advise that investors sell ACB, while 8 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 0 others rate it as a “buy”.
What is ACB’s price target for the next 12 months?
Analysts predict a range of price targets between $0.51 and $1.12, with a median target of $0.67. Taking a look at these predictions, the average price target given by analysts for Aurora Cannabis Inc. (ACB) stock is $0.74.
